drugset / Trial / NCT07419698
Evaluate the Safety, Tolerability, PK, and PD of JMT206 Injection in Healthy Participants
RandomizedParallel-groupSingle-blindTreatment
Summary
A This is a single-center, randomized, double-blind, placebo-controlled, dose-escalation Phase I clinical trial. It aims to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of a single administration of JMT206 Injection in healthy participants.
Timeline
- Start
- 2026-01-26
- Primary completion
- 2026-09-01
- Completion
- 2026-11-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | JMT206 | Unknown | — | Subcutaneous |
Indications
No indication recorded.